Evalion is building the AI‑native platform for clinical trials. Every drug that reaches patients passes through a process that's barely changed in fifty years — manual coordination, years of delay, billions in cost, and lives lost along the way. We're replacing that machinery with AI agents that source patients, run pre‑screening, and monitor compliance in real time, all inside an audit architecture regulators trust.

Founded by Marcelo (serial entrepreneur — his last company scaled from zero to $1B+ revenue), Miguel (ex‑Google engineering leader, pioneer of conversational AI agents in healthcare), and Mo (physician with two decades as a healthcare investor and policy advisor). Product and engineering are based in Barcelona; commercial in Boston/NYC. Backed by Javier Olivan (COO, Meta), Fidji Simo (CEO Applications, OpenAI), Guillermo Rauch (CEO, Vercel), and top institutional AI investors. We're assembling a small, elite team with general ambition.

Joining at day 0 ...